HomeOCUL • NASDAQ
add
Ocular Therapeutix Inc
Previous close
$6.27
Day range
$6.05 - $6.26
Year range
$2.00 - $11.31
Market cap
955.66M USD
Avg Volume
3.02M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 14.77M | 10.47% |
Operating expense | 24.33M | 21.88% |
Net income | -64.85M | -113.89% |
Net profit margin | -438.93 | -93.63% |
Earnings per share | -0.24 | 21.82% |
EBITDA | -30.70M | -39.11% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 482.89M | 511.05% |
Total assets | 538.95M | 319.18% |
Total liabilities | 130.96M | 10.18% |
Total equity | 407.98M | — |
Shares outstanding | 154.89M | — |
Price to book | 2.37 | — |
Return on assets | -19.99% | — |
Return on capital | -24.06% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -64.85M | -113.89% |
Cash from operations | -33.89M | -69.66% |
Cash from investing | -255.00K | 92.45% |
Cash from financing | 321.22M | 411,724.36% |
Net change in cash | 287.08M | 1,333.48% |
Free cash flow | -24.71M | -52.26% |
About
Founded
2006
Headquarters
Website
Employees
267